Literature DB >> 19622861

The three-dimensional structure of MAP kinase p38beta: different features of the ATP-binding site in p38beta compared with p38alpha.

Sangita B Patel1, Patricia M Cameron, Stephen J O'Keefe, Betsy Frantz-Wattley, Jed Thompson, Edward A O'Neill, Trevor Tennis, Luping Liu, Joseph W Becker, Giovanna Scapin.   

Abstract

The p38 mitogen-activated protein kinases are activated in response to environmental stress and cytokines and play a significant role in transcriptional regulation and inflammatory responses. Of the four p38 isoforms known to date, two (p38alpha and p38beta) have been identified as targets for cytokine-suppressive anti-inflammatory drugs. Recently, it was reported that specific inhibition of the p38alpha isoform is necessary and sufficient for anti-inflammatory efficacy in vivo, while further inhibition of p38beta may not provide any additional benefit. In order to aid the development of p38alpha-selective compounds, the three-dimensional structure of p38beta was determined. To do so, the C162S and C119S,C162S mutants of human MAP kinase p38beta were cloned, expressed in Escherichia coli and purified. Initial screening hits in crystallization trials in the presence of an inhibitor led upon optimization to crystals that diffracted to 2.05 A resolution and allowed structure determination (PDB codes 3gc8 and 3gc9 for the single and double mutant, respectively). The structure of the p38alpha C162S mutant in complex with the same inhibitor is also reported (PDB code 3gc7). A comparison between the structures of the two kinases showed that they are highly similar overall but that there are differences in the relative orientation of the N- and C-terminal domains that causes a reduction in the size of the ATP-binding pocket in p38beta. This difference in size between the two pockets could be exploited in order to achieve selectivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622861     DOI: 10.1107/S090744490901600X

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  12 in total

1.  The crystal structure of phosphorylated MAPK13 reveals common structural features and differences in p38 MAPK family activation.

Authors:  Zeynep Yurtsever; Suzanne M Scheaffer; Arthur G Romero; Michael J Holtzman; Tom J Brett
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-03-26

2.  The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor.

Authors:  John P Duffy; Edmund M Harrington; Francesco G Salituro; John E Cochran; Jeremy Green; Huai Gao; Guy W Bemis; Ghotas Evindar; Vincent P Galullo; Pamella J Ford; Ursula A Germann; Keith P Wilson; Steven F Bellon; Guanging Chen; Paul Taslimi; Peter Jones; Cassey Huang; S Pazhanisamy; Yow-Ming Wang; Mark A Murcko; Michael S S Su
Journal:  ACS Med Chem Lett       Date:  2011-07-28       Impact factor: 4.345

3.  Profiling MAP kinase cysteines for targeted covalent inhibitor design.

Authors:  Ruibin Liu; Neha Verma; Jack A Henderson; Shaoqi Zhan; Jana Shen
Journal:  RSC Med Chem       Date:  2021-11-03

4.  The p38β mitogen-activated protein kinase possesses an intrinsic autophosphorylation activity, generated by a short region composed of the α-G helix and MAPK insert.

Authors:  Jonah Beenstock; Sheer Ben-Yehuda; Dganit Melamed; Arie Admon; Oded Livnah; Natalie G Ahn; David Engelberg
Journal:  J Biol Chem       Date:  2014-07-08       Impact factor: 5.157

5.  X-ray crystal structure of ERK5 (MAPK7) in complex with a specific inhibitor.

Authors:  Jonathan M Elkins; Jing Wang; Xianming Deng; Michael J Pattison; J Simon C Arthur; Tatiana Erazo; Nestor Gomez; Jose M Lizcano; Nathanael S Gray; Stefan Knapp
Journal:  J Med Chem       Date:  2013-05-17       Impact factor: 7.446

6.  Discovering and validating unknown phospho-sites from p38 and HuR protein kinases in vitro by Phosphoproteomic and Bioinformatic tools.

Authors:  Elena López; Isabel López; Julia Sequí; Antonio Ferreira
Journal:  J Clin Bioinforma       Date:  2011-07-06

7.  p38β, A novel regulatory target of Pokemon in hepatic cells.

Authors:  Zhe Chen; Feng Liu; Nannan Zhang; Deliang Cao; Min Liu; Ying Tan; Yuyang Jiang
Journal:  Int J Mol Sci       Date:  2013-06-27       Impact factor: 5.923

8.  Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction.

Authors:  D Martin Watterson; Valerie L Grum-Tokars; Saktimayee M Roy; James P Schavocky; Brinda Desai Bradaric; Adam D Bachstetter; Bin Xing; Edgardo Dimayuga; Faisal Saeed; Hong Zhang; Agnieszka Staniszewski; Jeffrey C Pelletier; George Minasov; Wayne F Anderson; Ottavio Arancio; Linda J Van Eldik
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

Review 9.  Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses.

Authors:  Yanyan Yang; Seung Cheol Kim; Tao Yu; Young-Su Yi; Man Hee Rhee; Gi-Ho Sung; Byong Chul Yoo; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2014-03-20       Impact factor: 4.711

10.  Roles of p38α and p38β mitogen‑activated protein kinase isoforms in human malignant melanoma A375 cells.

Authors:  Su-Ying Wen; Shi-Yann Cheng; Shang-Chuan Ng; Ritu Aneja; Chih-Jung Chen; Chih-Yang Huang; Wei-Wen Kuo
Journal:  Int J Mol Med       Date:  2019-10-24       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.